SCHEMBL295231

SCHEMBL295231

CCOC=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4624457 0.89
SCHEMBL28412386 0.84
SCHEMBL12828010 0.78
SCHEMBL4368259 0.76
SCHEMBL23529565 0.75
SCHEMBL11643044 0.75
SCHEMBL4430036 0.75
SCHEMBL11643042 0.75
SCHEMBL294858 0.75
SCHEMBL4430034 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108473484-B Compounds useful as TRPM8 modulators 弗门尼舍公司 2021-06-29 CN disclosed
US-9856340-B2 Photocurable fluorinated polymer composition ASAHI GLASS COMPANY, LIMITED (JP) 2018-01-02 US disclosed
CN-105541849-A 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as PDE9A inhibitors BOEHRINGER INGELHEIM INT 2016-05-04 CN disclosed
CN-103896921-B As compound and the composition of kinases inhibitor IRM LLC (BM) 2016-02-24 CN disclosed
CN-103052639-B 6-cycloalkyl-1, 5-dihydro-pyrazolo [3,4-d ] pyrimidin-4-one derivatives and their use as PDE9A inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-02-17 CN disclosed
CN-105143220-A Novel pyrazole derivatives HOFFMANN LA ROCHE 2015-12-09 CN disclosed
EP-2468816-B1 PHOTOCURABLE FLUORINATED POLYMER COMPOSITION ASAHI GLASS CO LTD (JP) 2014-11-26 EP disclosed
US-8796193-B2 Refrigerating machine oil compositions NIPPON OIL CORPORATION (JP) 2014-08-05 US disclosed
US-8399479-B2 Modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-03-19 US disclosed
US-8394828-B2 Quinoline-derived amide modulators of vanilloid VR1 receptor JANSSEN PHARMACEUTICA, NV (BE) 2013-03-12 US disclosed
US-6258507-B1 UNSATURATED AROMATIC ACRYLATED ESTER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-07-10 US disclosed
EP-1051381-A1 PROCESS FOR PREPARING HYDROFLUOROETHERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 2000-11-15 EP disclosed
US-6023002-A REACTION OF A FLUORINATED ALKOXIDE WITH AN ALKYL FLUOROVINYLALKYL ETHER, THE ALKYL FLUOROVINYLALKYL ETHER HAVING ALPHA-BETA CARBON-CARBON UNSATURATION RELATIVE TO THE ETHER OXYGEN 3M INNOVATIVE PROPERTIES COMPANY (US) 2000-02-08 US disclosed
EP-0955563-A1 A photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-11-10 EP disclosed
EP-0945764-A2 Photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-09-29 EP disclosed
WO-1999037598-A1 PROCESS FOR PREPARING HYDROFLUOROETHERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-07-29 WO disclosed
EP-0648769-A1 12-Hetero-substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizium salts and compositions and method of use thereof STERLING WINTHROP INC. (US) 1995-04-19 EP disclosed
US-5380729-A Treatment or prevention of neurodegenerative disorders or neurotoxic injuries STERLING WINTHROP INC. (US) 1995-01-10 US disclosed
US-4403098-A OXIDATION CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) 1983-09-06 US disclosed
US-4022804-A ADDITION REACTION; SULFONIC ACID BROMIDES, UNSATURATED COMPOUNDS BASF AKTIENGESELLSCHAFT (DT) 1977-05-10 US disclosed